Chronic proteinuric nephropathies: Outcomes and response to treatment in a prospective cohort of 352 patients with different patterns of renal injury

This publication has 14 references indexed in Scilit:

• Renoprotective properties of ACE-inhibition in non-diabetic nephropathies with non-nephrotic proteinuria
  The Lancet, 1999
• Glomerular size-selective dysfunction in NIDDM is not ameliorated by ACE inhibition or by calcium channel blockade
  Kidney International, 1999
• Pathophysiology of Progressive Nephropathies
  New England Journal of Medicine, 1998
• Urinary protein excretion rate is the best independent predictor of ESRF in non-diabetic proteinuric chronic nephropathies
  Kidney International, 1998
• Long-Term Effect of Lisinopril and Atenolol on Kidney Function in Hypertensive NIDDM Subjects With Diabetic Nephropathy
  Diabetes, 1997
• Effect of the Angiotensin-Converting–Enzyme Inhibitor Benazepril on the Progression of Chronic Renal Insufficiency
  New England Journal of Medicine, 1996
• Blood Pressure Control, Proteinuria, and the Progression of Renal Disease
  Annals of Internal Medicine, 1995
• The Effect of Angiotensin-Converting-Enzyme Inhibition on Diabetic Nephropathy
  New England Journal of Medicine, 1993
• Effect of antihypertensive treatment on kidney function in diabetic nephropathy.
  BMJ, 1987
• Repeated assessment of results in clinical trials of cancer treatment
  The British Journal of Radiology, 1971